Patent US4605413A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4605413A Expired / Lapsed US ⏱️ 0.0 years remaining

Stimulation of chemotaxis by chemotactic peptides

Assignee: UAB RESEARCH FOUNDATION NON-PROFIT CORP
•
Filing: 1983-09-19
•
Granted: 1986-08-12
•
Expires: 2003-09-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of stimulating chemotaxis toward a prosthetic device is disclosed, which method comprises incorporating a chemotactic peptide of the formula B1-X-(APGVGV)n-Y-B2 wherein A is a peptide-forming residue of L-alanine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; B1 is H or a biocompatible N-terminal group; B2 is OH, OB3 where B3 is a non-toxic metal ion, or a biocompatible C-terminal group; X is PGVGV, GVGV, VGV, GV, V, or a covalent bond; Y is APGVG, APGV, APG, AP, A, or a covalent bond; and n is an integer from 1 to 100; into a surface of the prosthetic device. Prosthetic devices which have the property of enhancing invasion of elastic fiber synthesizing fibroblasts as a result of the chemotactic peptide are also disclosed.

Inventors

  • 👤 Dan W. Urry
  • 👤 Robert M. Senior

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:47
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/29

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 111 words
A prosthetic device wherein a surface of said device has a chemotactic peptide of the formula B.sup.1 --X--(APGVGV).sub.n --Y--B.sup.2 wherein A is a peptide-forming residue of L-alanine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; B 1 is H or a biocompatible N-terminal group; B 2 is OH, OB 3 where B 3 is a non-toxic metal ion, or a biocompatible C-terminal group; X is PGVGV, GVGV, VGV, GV, V, or a covalent bond; Y is APGVG, APGV, APG, AP, A, or a covalent bond; and n is an integer from 1 to 100; incorporated into said surface.
Claim 2
Dependent Claim 111 words
A prosthetic device wherein a surface of said device has a chemotactic peptide of the formula B.sup.1 --X--(APGVGV).sub.n --Y--B.sup.2 wherein A is a peptide-forming residue of L-alanine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; B 1 is H or a biocompatible N-terminal group; B 2 is OH, OB 3 where B 3 is a non-toxic metal ion, or a biocompatible C-terminal group; X is PGVGV, GVGV, VGV, GV, V, or a covalent bond; Y is APGVG, APGV, APG, AP, A, or a covalent bond; and n is an integer from 1 to 100; incorporated into said surface.
Claim 3
Dependent Claim 12 words
The device of claim 12, wherein n is from 1 to 10.
Claim 4
Dependent Claim 10 words
The device of claim 1, wherein n is about 5.
Claim 5
Dependent Claim 9 words
The device of claim 1, wherein n is 1.
Claim 6
Dependent Claim 19 words
The device of claim 1, wherein said peptide is H--VGVAPG--OH, H--GVAPGV--OH, H--VAPGVG--OH, H--APGVGV--OH, H--PGVGVA--OH, H--GVGVAP--OH, or a salt thereof.
Claim 7
Dependent Claim 26 words
The device of claim 1, wherein B 1 is H and B 2 is OH or OB 3 where B 3 is an alkali metal ion.
Claim 8
Dependent Claim 28 words
The device of claim 1, wherein said amount is from 10 -9 to 10 -3 millimoles of hexamer or repeating unit per 100 cm 2 of said surface.
Claim 9
Dependent Claim 12 words
The device claim 1, wherein said prosthetic device comprises a structural polypeptide.
Claim 10
Dependent Claim 21 words
The device of claim 1, wherein said chemotactic peptide is incorporated using non-covalent bonding between said chemotactic peptide and said surface.
Claim 11
Dependent Claim 21 words
The device of claim 1, wherein said chemotactic peptide is incorporated using covalent bonding between said chemotactic peptide and said surface.
Claim 12
Dependent Claim 12 words
The device of claim 10, wherein said surface comprises a structural peptide.

References Cited (Backward Citations)

US4132746A Cited
US4273873A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-08-11 1990-02-10 1990-08-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-08-11 1994-02-10 1994-08-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-08-11 1998-02-10 1998-08-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag